Caricamento...
Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same?
Prostate cancer (PCa) is the most common cancer in men. Androgen receptor axis plays a crucial role in the carcinogenesis of PCa. The mainstay treatment of prostate cancer is blockage of androgen receptor axis but in a vast majority of patient resistance to androgen deprivation therapy is inevitable...
Salvato in:
| Pubblicato in: | Prostate Int |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Asian Pacific Prostate Society
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8053696/ https://ncbi.nlm.nih.gov/pubmed/33912507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prnil.2020.03.002 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|